| Field | Specification |
|---|---|
| Target | |
| Alternative names | Nuclear factor erythroid 2-related factor 2; NF-E2-related factor 2; NFE2-related factor 2; Nrf-2; Nuclear factor, erythroid derived 2, like 2; NFE2L2; NRF2 |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | E.coli-derived human NFE2L2 recombinant protein (Position: R34-N605). |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody targets nuclear factor erythroid 2-related factor 2 (gene NFE2L2) in human samples and is validated for Western blot, IHC, ICC/IF, flow cytometry and ELISA. The predicted molecular weight is 67.8 kDa, and the supplier reports an observed band at about 100 kDa.
NRF2 (NFE2L2) is a CNC-bZIP transcription factor that controls the cellular antioxidant response. Under normal conditions KEAP1 targets it for degradation, but oxidative or electrophilic stress stabilizes NRF2, which then binds antioxidant response elements to induce detoxifying and cytoprotective genes, making it central to redox biology.
| Target | Nuclear factor erythroid 2-related factor 2 (gene NFE2L2; UniProt Q16236, human) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Reactivity | Human |
| Form | Lyophilized |
| Formulation | Per vial: 4 mg trehalose; 0.9 mg NaCl; 0.2 mg Na2HPO4; 0.01 mg NaN3 |
| Calculated MW | 67.8 kDa |
| Observed MW | 100 kDa |
| Storage | As supplied: −20 °C for up to 12 months from receipt. After reconstitution: 4 °C for up to 1 month, or aliquot and keep at −20 °C for up to 6 months. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 0.25–0.5 µg/mL (Human) |
|---|---|
| IHC (paraffin sections) | 2–5 µg/mL (Human) |
| Immunocytochemistry / Immunofluorescence | 5 µg/mL (Human) |
| Flow cytometry (fixed cells) | 1–3 µg/1×106 cells (Human) |
| ELISA | 0.1–0.5 µg/mL |
Samples with a confirmed band (WB): human HepG2 cells, human SW620 cells.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 5–20% gradient SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 0.5 µg/mL overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (IHC): human mammary cancer tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Conditions in the example images (IHC): heat-mediated antigen retrieval in EDTA buffer (pH 8.0).
Samples with confirmed staining (ICC/IF): U2OS cells.
Samples with a confirmed signal (flow cytometry): 293T cells.
Immunogen
Recombinant human NFE2L2 fragment (Arg34–Asn605), expressed in E. coli.
Reactivity Notes
The supplier lists reactivity with human. UniProt places nuclear factor erythroid 2-related factor 2 in the cytoplasm and nucleus. Tissue expression noted by UniProt (human): Widely expressed. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Wang Daquan et al. (2022) Protection of zero-valent iron nanoparticles against sepsis and septic heart failure. Journal of Nanobiotechnology. 10.1186/s12951-022-01589-1
Jiang-Hong Luo et al. (2023) Untargeted serum and liver metabolomics analyses reveal the gastroprotective effect of polysaccharide from Evodiae fructus on ethanol-induced gastric ulcer in mice. International Journal of Biological Macromolecules. 10.1016/j.ijbiomac.2023.123481
Zhiwei Zhang et al. (2023) Secoisolariciresinol diglucoside Ameliorates Osteoarthritis via Nuclear factor-erythroid 2-related factor-2/ nuclear factor kappa B Pathway: In vitro and in vivo experiments. Biomedicine & Pharmacotherapy. 10.1016/j.biopha.2023.114964
Xiao Ji et al. (2021) Maresin conjugates in tissue regeneration-1 suppresses ferroptosis in septic acute kidney injury. Cell and Bioscience. 10.1186/s13578-021-00734-x
Wenhua Chen et al. (2024) Baicalin-2-ethoxyethyl ester alleviates gentamicin-induced acute kidney injury via NF-κB signaling pathway. Biomedicine & Pharmacotherapy. 10.1016/j.biopha.2024.116276
Zheng Wang et al. (2022) Protective effects and mechanisms of lycorine against adriamycin-induced cardiotoxicity. Phytomedicine. 10.1016/j.phymed.2022.154178
Hai-Yan Ni et al. (2022) Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPARα/PGC-1α-mediated mitochondrial oxidative metabolism. Phytomedicine. 10.1016/j.phymed.2021.153919
Yun-Tao Zhao et al. (2022) Tilapia Skin Peptides Ameliorate Cyclophosphamide-Induced Anxiety- and Depression-Like Behavior via Improving Oxidative Stress, Neuroinflammation, Neuron Apoptosis, and Neurogenesis in Mice. Frontiers in Nutrition. 10.3389/fnut.2022.882175
Wangrui Lei et al. (2022) Psoralidin protects against cerebral hypoxia/reoxygenation injury: Role of GAS6/Axl signaling. Phytotherapy Research. 10.1002/ptr.7481
Aizhen Zhao et al. (2025) Mangiferin Attenuates Myocardial Ischemia Reperfusion Injury by Regulating the GAS6/Axl Signaling Pathway. Phytotherapy Research. 10.1002/ptr.8423
